News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioAlliance Pharma Announces: New Achievements in Clonidine Lauriad™ Clinical Development, Second Product of Its Orphan Oncology Portfolio


4/17/2012 10:29:42 AM

PARIS--(BUSINESS WIRE)--Regulatory News: “Beyond optimizing the product development, the expansion of our trial in Europe enables us to already involve a great number of specialists, part of our future prescriber network” BioAlliance Pharma SA (Paris:BIO), a Company dedicated to specialty and orphan pharma products in oncology and supportive care, today announces new achievements in its phase II clinical trial with clonidine Lauriad™.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES